GlassScriptPhysician profile
Susan C Erk
NPI 1477520203
$13,531.34
in general payments reported to CMS, 2019-2025
42 companies · $1,208 in 2025
The $1,208 reported for 2025 was more than what 92% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,491 · 2020: $935 · 2021: $719 · 2022: $985 · 2023: $4,965 · 2024: $1,227 · 2025: $1,208.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,125 · Food and Beverage: $3,155 · Education: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,125.00 |
| Food and Beverage | $3,155.18 |
| Education | $119.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $4,412.20 | 2021-2025 | Nexplanon, Nuvaring |
| Merck Sharp & Dohme LLC | $2,249.41 | 2019-2024 | Gardasil, Gardasil 9 |
| Abbvie INC. | $754.52 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $679.04 | 2021-2025 | |
| Therapeuticsmd, INC. | $590.41 | 2019-2022 | |
| Astellas Pharma US INC | $544.33 | 2019-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $501.04 | 2020-2025 | Slynd |
| Pfizer INC. | $362.17 | 2019-2025 | |
| Coopersurgical, INC. | $315.05 | 2019-2025 | Paragard T 380a, Summit Doppler, Paragard T 380a |
| Daiichi Sankyo INC. | $282.01 | 2019-2024 | Injectafer |
| Sumitomo Pharma America, INC. | $272.40 | 2023-2025 | Myfembree |
| Amgen INC. | $261.41 | 2019-2025 | Prolia, Evenity |
| Agile Therapeutics, INC. | $212.54 | 2021-2024 | Twirla |
| Exact Sciences Corporation | $192.67 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amag Pharmaceuticals, INC. | $189.49 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $188.89 | 2019-2020 | |
| Millicent US INC | $163.64 | 2019-2025 | Femlyv, Intrarosa, Femring |
| Bayer Healthcare Pharmaceuticals INC. | $158.12 | 2021-2025 | |
| Duchesnay USA Incorporated | $153.75 | 2019 | |
| Biogen, INC. | $139.76 | 2024-2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $112.30 | 2019-2025 | Aptima |
| Novo Nordisk INC | $100.87 | 2019-2025 | Wegovy |
| Mylan Pharmaceuticals INC. | $97.23 | 2021-2022 | |
| Lilly USA, LLC | $68.79 | 2024-2025 | Zepbound, Jardiance |
| Dexcom, INC. | $58.00 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $49.34 | 2025 | Truclear |
| Avation Medical, INC. | $48.76 | 2025 | Vivally System |
| Myovant Sciences INC. | $48.68 | 2022 | |
| Vertical Pharmaceuticals, LLC | $42.67 | 2019 | |
| Ge Healthcare | $37.61 | 2019 | |
| Boston Scientific Corporation | $29.39 | 2023 | |
| Scynexis, INC. | $27.31 | 2022 | |
| Alexion Pharmaceuticals, INC. | $24.56 | 2019 | |
| Valencia Technologies Corporation | $23.72 | 2025 | Ecoin Device Kit |
| Allergan, INC. | $22.65 | 2019-2020 | |
| Mission Pharmacal Company | $19.58 | 2019 | |
| Roche Diagnostics Corporation | $17.19 | 2021 | |
| Neuronetics, INC. | $16.99 | 2019 | |
| Coloplast Corp | $15.83 | 2019 | |
| Meditrina | $15.81 | 2022 | |
| Evofem Biosciences, INC. | $15.62 | 2021 | |
| Shield Therapeutics INC | $15.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Erk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.